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INTRODUCTION:  Herein  we  present  an  extremely  rare  case  of  a giant  extra  gastrointestinal  stromal  tumor
(EGIST)  of  the  lesser  omentum  obscuring  the  diagnosis  of a choloperitoneum.
PRESENTATION OF  CASE:  A  79 years  old female  was  admitted  to our hospital  with  symptoms  of  vomiting
and  epigastric  pain.  Abdominal  computer  tomography  revealed  a  sizable  formation  that was  diagnosed
as  a tumor  of  the  pancreas.  In  laparotomy,  a choloperitoneum  was  diagnosed  as  the cause  of  patient’s
symptoms.  A tumor  adherent  ﬁrmly  to the  lesser  curvature  of  stomach  was  also  discovered.  Cholecys-
tectomy  and  subtotal  gastrectomy  were  performed.  Histologically,  the  tumor  was  diagnosed  as  a  EGIST
of  the  lesser  omentum.  The  patient did  not  receive  any  adjuvant  therapy  and  after two  years  of follow  up
she  is  without  any  recurrence.
DISCUSSION: Omental  EGISTs  may  remain  clinically  silent  despite  the  large  tumor’s  size.  It is  difﬁcult  to
differentiate  a EGIST  in  the  lesser  omentum  from  a GIST  of the  lesser  curvature  of  the  stomach,  despite  the
use  of  advanced  radiological  imaging  techniques.  Our  case  of a  giant  EGIST  of lesser  omentum  obscuring
the  diagnosis  of  acute  choloperitoneum  is the  only  one  reported  in  literature.
CONCLUSION: EGISTs  that arise  from  the  omentum  are  very  rare  and  complete  surgical  resection  is  the
only  effective  treatment  approach.  Adjuvant  therapy  following  resection  of localized  disease  has  become
standard  of  care  in  high  risk  cases.
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. Introduction
Gastrointestinal stromal tumors (GISTs) are the most common
esenchymal neoplasms of the gastrointestinal tract, accounting
or 0.1–3% of all gastrointestinal malignancies.1 These tumors are
ypically discovered in symptomatic patients (e.g., gastrointesti-
al bleeding, abdominal pain) or incidentally in asymptomatic
atients (e.g., diagnostic tests, during abdominal surgery, present
n surgical specimens). They are characterized by the expression
f KIT (CD117) a transmembrane tyrosine kinase receptor for stem
ell factor.2 GISTs are rarely found as primary tumors in extra-
astrointestinal intra-abdominal tissues such as the omentum,
he mesentery and the retroperitoneum (EGISTs).3 The origin
f EGISTs is uncertain, but their histological appearance and
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immunophenotype are identical to the classic GISTs.4 Our knowl-
edge about EGISTs is based on accumulated data from individual
case reports. In this paper, we  describe a rear case of EGIST
of lesser omentum, that confused us of making diagnosis of a
choloperitoneum.
2. Presentation of case
A  79 years old female, was admitted to the emergency clinic
with symptoms of vomiting and epigastric pain during the last
24 h. Her medical history included atrial ﬁbrillation as well as
respiratory failure. Physical examination revealed painful epigas-
tric distension. Laboratory tests revealed Hb: 12.1 g/dL, Hct 36.2%,
WBC: 8000/mm3, gran: 71.5%, lymph: 18.2% and serum levels of
glucose: 147 mg/dL, urea: 39 mg/dL, creatinine: 0.90 mg/dL, T.bil:
0.50 mg/dL, D.bil: 0.19 mg/dL, SGOT: 18 IU/L, SGPT: 15 IU/L, -GT:
19 IU/L, amylase: 89 IU/L, lipase: 52 IU/L. Abdominal X-ray exam-
ination was normal. Axial CECT demonstrated a large lobulated
Open access under CC BY license.mass measuring 10.77 × 9.67 cm between the lesser curvature of
the stomach and the body of pancreas. The mass demonstrated
post-contrast heterogeneous enhancement with large necrotic
areas. It was diagnosed as a tumor of the pancreas. There were
s Ltd. Open access under CC BY license.
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sured 7 cm in length and 3 cm in width and was  full of multiple small
stones and the histopathology revealed intense inﬂammation and
focal wall necroses of its wall.ig. 1. (A and B) Abdominal computer tomography scan demonstrating a sizable
ormation contiguous with the stomach and the pancreas.
adiologic features of acute cholecystitis, while the liver
arenchyma appeared to be normal (Fig. 1).
A nasogastric tube was inserted and parenteral ﬂuid therapy
as administered. During the following 48 h the patient dete-
iorated clinically with signs of acute abdomen comprising of
pigastric pain radiating to the rest of the abdomen and generalized
uarding of the anterior abdominal muscles. There was  also dete-
ioration of the hematology and biochemistry indices (Hct: 39%,
BC: 17,040/mm3, gran: 81.5%, lymph: 5.8%, urea: 46 mg/dL, cre-
tinine: 1.70 mg/dL). Abdominal ultrasound examination revealed
ree ﬂuid in all abdominal quadrants.
After that, under general anesthesia, the patient underwent an
xploratory laparotomy by midline incision. The peritoneal cav-
ty was full of bilious liquid and bile-colored pseudomembranes.
here was thickening of the gallbladder wall with focal necroses.
here was also a sizable mass with a diameter of about 10 cm,  ﬁrmly
dherent to the lesser curvature of stomach and the pancreas. The
umor was in contact with the left gastric artery (Fig. 2). Chole-
ystectomy was performed along with lavage of the peritoneal
avity. Dissection of the tumor from the stomach was  deemedFig. 2. Surgical ﬁeld: choloperitoneum, focal necroses of the gallbladder and a siz-
able  formation adherent ﬁrmly to the lesser curvature of the stomach.
unfeasible since there were no identiﬁable tumor margins on the
stomach wall. Therefore we  proceeded with resection of the tumor
en-block with the adjacent part of the stomach (subtotal gastrec-
tomy) and resection of the lesser omentum. The gastrointestinal
continuity was restored with a Bilroth II procedure (Fig. 3). The
patient, because of her respiratory problems, was transferred to
the Intensive Care Unit and was connected to the ventilator.
The tumor was well circumscribed in the lesser omentum
(Fig. 4), measuring 11 cm × 9 cm × 9 cm.  There was no inﬁltration
to stomach. The cut surface appear reddish-gray, solid. The his-
tological features characterized by fascicles of spindle cells with
monotonous and uniform nuclei, without atypia. There were foci of
tumor cell necrosis. Mitotic activity was 7/50 HRF. Immunohisto-
chemically the tumor cells were diffusely positive for c-kit (CD117),
CD34 and slightly positive for SMA  but negative for DESMINE and
S-100 proteine. The MIB-1 index was <5%. The gallbladder was mea-Fig. 3. Surgical specimen of cholecystectomy and subtotal gastrectomy.
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Authors’ contributionsig. 4. EGIST arising in lesser omentum with a pushing margin extending to the fat.
Recovery was prolonged because of the patient’s respiratory
ailure; she was disconnected from the ventilator on the 11th post-
perative day and she was discharged on 20th postoperative day.
he patient did not receive any additional adjuvant treatment,
ccording to the attending oncologist and after two years of follow
p she is without any recurrence.
. Discussion
Gastrointestinal stromal tumors are the most common mes-
nchymal neoplasms of the gastrointestinal tract, accounting for
.1–3% of all gastrointestinal malignancies. They are currently
elieved to originate from the interstitial cells of Cajal (ICCs) or
heir precursors in the gastrointestinal tract.2 Cajal cells are the only
nes along the GI tract that exhibit the CD117+/CD34+ immunophe-
otype, which is the diagnostic hallmark of GIST.5 The molecular
athogenesis of GISTs is usually driven by activating mutations of
he KIT gene that encodes the CD117 oncoprotein. Typically they
re characterized by the expression of KIT (CD 117), a transmem-
rane tyrosine kinase reseptor for stem cells factor, in 90% of cases,
lthough in some cases CD117 may  be negative.6 CD34 strongly
nd diffuse stains approximately 70% of GISTs. GISTs may  show
mooth muscle actine positivity but are negative for desmin and
-100 protein.3
GISTs can occur anywhere interstitial cells of Cajal are present
long the gastrointestinal tract, including the stomach (60%), small
ntestine (30%), duodenum (5%), colorectum (4%) and esophagus.7
ISTs originating from extragastrointestinal intra-abdominal tis-
ues (EGISTs) are located in the omentum and mesentery in 80% of
ases. EGISTs were also reported in pleura, pancreas and abdomi-
al wall8 Lesser omental EGISTs are particularly rare and only seven
ases have been previously reported.9
The origin of EGISTs is uncertain but, as a rule, there is a strong
nalogy between GISTs and EGISTs from histological aspect. EGISTs
n the lesser omentum may  theoretically arise from CD117+/CD34+
esenchymal cells, like Cajal cells in the normal omentum.10
The clinical presentation of GISTs is erratic. About 70% of patients
re symptomatic and GISTs are associated with a broad range
f presentations, including bleeding, perforation and most com-
only obstruction.10,11 However, approximately 30% of cases are
symptomatic and they are diagnosed as incidental ﬁndings dur-
ng endoscopy, surgery, radiologic studies for other reasons or at
utopsy.12 There are no physical ﬁndings speciﬁc to GISTs. The
ost frequent non-speciﬁc presenting complaint is of an abdomi-
al mass. Omental EGISTs may  remain clinically silent despite the
arge tumor size13 as in our case.PEN  ACCESS
Surgery Case Reports 4 (2013) 818– 821
Contrast-enhanced Computer Tomography is the imaging test
of choice for detecting, staging, surgical planning and moni-
toring of patients with GISTs.14 The EGISTs of lesser omentum
occur as large, well-circumscribed, post-contrast heterogeneously
enhanced tumors with areas of necrosis and hemorrhage, as in our
case.
It is difﬁcult to differentiate an EGIST in the lesser omentum
from a GIST of the lesser curvature of the stomach, despite the use
of advanced radiological imaging techniques such as CT or abdom-
inal ultrasound. About half of omental EGISTs are misdiagnosed as
extra mucosal tumors of the stomach.15 In our case, the CT images
suggested a huge tumor most likely originating from the pancreas.
Our patient’s symptomatology of acute abdomen was  though to be
due to rupture of the tumor. It was under these circumstances that
we decided to perform an exploratory laparotomy. Intraoperatively
the origin of the tumor could not be macroscopically determined
since it was ﬁrmly adherent to the lesser curvature of the stom-
ach. Complete tumor resection was  achieved by performing a distal
subtotal gastrectomy with Bilroth II reconstruction.
There is a general agreement that tumor’s size and mitotic
count are the most important prognostic factors in GISTs.16 Malig-
nancy characteristics of GISTs on CT are diameter greater than 5 cm,
irregular surface, indeterminate limits, tissue inﬁltration, hetero-
geneous contrast enhancement, hepatic metastasis and peritoneal
dispersion. The lymph node swelling is not a factor associated with
malignant GIST and rarely they manifest ascites. A high mitotic
rate (>5/50HRF), the high cellularity and necrosis show a possible
aggressive clinical course of EGISTs, while the existence of two  or
more of these three factors have a poor prognosis. The size criterion
is not as important for the prognosis of EGISTs as it is for GISTs.4
Surgical resection remains the treatment of choice for localized
GISTs. All incidental GISTs in the published reports were deter-
mined to have low or very low risk of malignant potential. Imatinib
mesylate, which is an inhibitor of a family of structurally related
tyrosine kinase signaling enzymes, and sunitinibe, which is a multi
kinase inhibitor, are currently the most effective adjuvant ther-
apy for GISTs pro or postoperatively,17 while a careful follow-up
is needed to rule out late recurrence or metastasis.
4. Conclusion
EGISTs that arise from the omentum are very rare and complete
surgical resection is the only effective treatment approach. Adju-
vant therapy following resection of localized disease has become
standard of care in high risk cases.
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